A Synergistic System: Urolithin A, CoQ10, & PQQ
UA.01: The Advanced Mitochondrial Renewal Protocol
As early as age 30, the body’s ability to recycle damaged mitochondria, a process called Mitophagy, begins to decelerate. This leads to a buildup of "cellular debris," resulting in reduced ATP (energy) production and overall cellular resilience and longevity.
The TriPhase Mito System™ MOA
How UA.01 orchestrates cellular renovation through three distinct biological stages.
Urolithin A (UA): Mitophagy & Cellular Maintenance
The Biological Objective:
Support the natural maintenance of cellular efficiency.
The Mechanism:
Urolithin A is studied for its role in supporting the PINK1/Parkin signaling pathway.
The Outcome:
These units are identified and incorporated into natural recycling pathways, supporting overall cellular resilience.
Clinical Impact:
Clinical data observed to support a significant increase in mitophagy markers.
Pyrroloquinoline quinone (PQQ): Mitochondrial Density & Longevity
The Biological Objective:
Expand the cellular energy infrastructure.
The Mechanism:
Within the cellular environment, PQQ is studied for its role in the PGC-1α pathway, a key factor in mitochondrial maintenance.
The Outcome:
This phase signals your cells to support the natural synthesis of new mitochondrial networks.
Clinical Impact:
PQQ has been observed to be highly efficient in supporting redox cofactors during natural cellular cycles.
Coenzyme Q10 (CoQ10): The ATP Energy Factor
The Biological Objective:
Support sustained energy maintenance.
The Mechanism:
The Electron Transport Chain (ETC) in the newly formed mitochondria is supported using Ubiquinol (CoQ10).
The Outcome:
By facilitating efficient electron transfer, the system supports the natural synthesis of ATP, the fundamental unit of human energy, while maintaining low free radical levels.
Clinical Impact:
Ubiquinol (the active ingredient of CoQ10) is shown to support the majority of total human cellular energy production.
Advanced Synergies: Urolithin A, CoQ10, and PQQ
We don't "label dress" with trace amounts. UA.01 is formulated with clinically relevant levels designed to match or exceed the levels used in peer-reviewed human research.
Urolithin A (500mg)
PQQ (20mg)
Coenzyme Q10 (240mg)
The Network Synergy
Relevant Endpoints: Peer-Reviewed Research on our Bio-Actives
Third-Party Validation Every batch of UA.01 undergoes rigorous testing for:
Purity
Verification of active compound concentrations via HPLC.
Safety
Screening for heavy metals (Lead, Mercury, Arsenic) and microbial contaminants.
Integrity
100% Glyphosate-free and Non-GMO.
See Current Certificate of Analysis (COA) PDF
Click Here to See our Most Recent COA